Drug development advancements call for skilled workforce According to a leader from Saama Technologies, keeping competitive in the face of technology evolution requires staff that can keep up with the changes. Suresh Katta, CEO and founder of Saama Technologies, spoke with Outsourcing-Pharma about the rapid technological advancements in the drug development field, and how companies can cultivate a workforce capable of keeping up. OSP: Could you please talk about some of the shifts in and demands on the clinical trial industry that are changing what we expect of study and drug-development personnel? SK: We are beginning an exciting new era when drug development teams can look at artificial intelligence (AI) as a welcomed new co-worker. AI is enabling them to take clinical study strategy and design to a superior level.